Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease.

Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease.
Related ArticlesLateralization of cochlear dysfunction as a specific biomarker of Parkinson's disease. Brain Commun. 2020;2(2):fcaa144 Authors: Sisto R, Viziano A, Stefani A, Moleti A, Cerroni R, Liguori C, Garasto E, Pierantozzi M Abstract In the last decade, animal studies highlighted the sensitivity of hearing function to lack of specific cochlear dopamine receptors, while several studies on humans reported association between ... read more
Source: PubMedPublished on 2020-12-31